PortalPublikationenAllogeneic hematopoietic cell transplantation (allo-HCT) out...

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)

Standard

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT). / Beksac, Meral; Kröger, Nicolaus; Byrne, Jennifer L; Ganser, Arnold; Yeğin, Zeynep Arzu; Schönland, Stefan.

in: BONE MARROW TRANSPL, Jahrgang 56, Nr. 3, 03.2021, S. 529-531.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Beksac, M, Kröger, N, Byrne, JL, Ganser, A, Yeğin, ZA & Schönland, S 2021, 'Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)', BONE MARROW TRANSPL, Jg. 56, Nr. 3, S. 529-531. https://doi.org/10.1038/s41409-020-01010-1

APA

Beksac, M., Kröger, N., Byrne, J. L., Ganser, A., Yeğin, Z. A., & Schönland, S. (2021). Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPL, 56(3), 529-531. https://doi.org/10.1038/s41409-020-01010-1

Vancouver

Beksac M, Kröger N, Byrne JL, Ganser A, Yeğin ZA, Schönland S. Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPL. 2021 Mär;56(3):529-531. https://doi.org/10.1038/s41409-020-01010-1

Bibtex

@article{a0ff6ad0adfe41d881bd19af2e303aac,
title = "Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)",
author = "Meral Beksac and Nicolaus Kr{\"o}ger and Byrne, {Jennifer L} and Arnold Ganser and Yeğin, {Zeynep Arzu} and Stefan Sch{\"o}nland",
year = "2021",
month = mar,
doi = "10.1038/s41409-020-01010-1",
language = "English",
volume = "56",
pages = "529--531",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "3",

}

RIS

TY - JOUR

T1 - Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT)

AU - Beksac, Meral

AU - Kröger, Nicolaus

AU - Byrne, Jennifer L

AU - Ganser, Arnold

AU - Yeğin, Zeynep Arzu

AU - Schönland, Stefan

PY - 2021/3

Y1 - 2021/3

U2 - 10.1038/s41409-020-01010-1

DO - 10.1038/s41409-020-01010-1

M3 - Other (editorial matter etc.)

C2 - 32741961

VL - 56

SP - 529

EP - 531

JO - BONE MARROW TRANSPL

JF - BONE MARROW TRANSPL

SN - 0268-3369

IS - 3

ER -